Navigation Links
MaxCyte to Present at the BIO CEO & Investor Conference
Date:2/6/2008

GAITHERSBURG, Md., Feb. 6 /PRNewswire/ -- MaxCyte, Inc., a clinical-stage therapeutics company and pioneer in clinical, non-viral cell loading systems, announces Douglas Doerfler, President & CEO, will be presenting at the BIO CEO & Investor Conference in New York, Waldorf=Astoria, on Monday, February 11, 2008 at 11:45AM.

Mr. Doerfler will provide a brief corporate overview and discuss the company's preclinical and clinical product portfolio, partnering candidates, and enabling technology for therapeutic development and biotherapeutic manufacturing.

About MaxCyte

MaxCyte is a clinical-stage cell therapeutics company with a rapidly growing pipeline of product development partnerships in cell-based therapies. The Company's proprietary, non-viral, ex vivo cell loading technology provide safety, scalability and reproducibility capabilities which are fundamental to commercializing successful cell-based therapies. MaxCyte has demonstrated the value of its versatile technology in partnered therapeutic programs in oncology, pulmonary, metabolic and infectious diseases as well as in development collaborations with leading researchers. Current clinical programs with MaxCyte-engineered cells include: a Phase IIa clinical study for treatment of chronic lymphocytic leukemia (CLL) and a Phase IIa study using engineered stem cells for the treatment of primary Pulmonary Arterial Hypertension (PAH). MaxCyte has recently partnered with Medinet (JP) to commercialize a cell based therapy to be launched in 2008. In addition, there are advanced preclinical programs in oncology and regenerative medicine. More than 16 commercial and academic partners are currently using the MaxCyte technology. The MaxCyte system has an FDA Master File in place at the Center for Biologics Evaluation and Research (CBER).

For more information, visit http://www.maxcyte.com.


'/>"/>
SOURCE MaxCyte, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. MaxCyte to Present at the Phacilitate Cell and Gene Therapy Forum 2008
2. Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference
3. HMS Holdings Corp. to Present at 2008 UBS Global Healthcare Services Conference
4. West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference
5. Sharps Compliance Corp. to Present at the RedChip Small-Cap Investor Conference in Scottsdale, Arizona
6. Vical to Present at BIO CEO and Investor Conference
7. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
8. NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
9. DURECT to Present at BIO CEO Investor Conference 2008
10. BIO CEO & Investor 2008 Conference to Webcast Millennium Presentation
11. Bush Budget Represents Double Whammy Hit on U.S. Seniors Medicare-Financed Nursing Facility Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., , SOUTHBRIDGE, Mass., Dec. 3 /PRNewswire/... approval to treat its first patients, Harrington ...t seeing patients immediately," said Diane Becquar..., The approval was granted today by the Massachu...ty and quality review of the facility. ,, The ...
(Date:12/3/2009)..., , BEIJING, Dec. 3 /PRNewswire-Asia/...enefits, ginger, one of the most important ingredi...in China during this flu season. , The ti... supply shortages,effecting upward price pressure...potential repeat of the current demand hysteria ov...
(Date:12/3/2009)..., , SILVER SPRING, Md., Dec. 3 /PRNewsw...g a health care system that ensures affordable, qu...on urges all Americans to contact their representa...h care reform. ,, See video from ANA at: http:...dvocating for a health care system that focuses on...
(Date:12/3/2009)...Roles of aggressor, victim often play out at schoo...c. 3 (HealthDay News) -- School bullies are also l... according to an Italian study that included 195 c...rticipants -- all with a sibling no more than four...ether they bullied or were bullied at school or at...
(Date:12/3/2009)...Finding could aid in eventual development of scree...DAY, Dec. 3 (HealthDay News) -- New research point...amin D and heart disease. , People with high bl...itamin D activation in the body were found to be t...e congestive heart failure, the study found. , ...
Breaking Medicine News(10 mins):Health News:Cancer Center at Harrington to Begin Seeing Patients 2Health News:Cancer Center at Harrington to Begin Seeing Patients 3Health News:Ginger Prices Could Skyrocket on H1N1 Fears 2Health News:VIDEO from Medialink and the American Nurses Association (ANA): American Nurses Association Urges All Americans to Take Part in Health Care Reform Debate 2Health News:Bullies May Intimidate Siblings, Too 2Health News:Vitamin D May Be Tied to Heart Disease Via Genes 2
...-- For the second year in a row and the third tim...dwide,s agency network won more creative awards th...ernational RX Club Show. , , Nine McCann Hea...ide agencies include Caudex Medical, echo Torre La...
...ersity of Texas M. D. Anderson Cancer Center marke...cate breast cancer in Panama through the Partnersh... Americas today at an event with Laura Bush, the F...Department of State and Susan G. Komen for the Cur...
... announcement, Governor,Schwarzenegger recommended...ry" items such as veterinary services, which is su...lation. Animal welfare advocates across the state...nimals are family members and taking care of their...
...lar disease are not given adequate drug therapy. T...e current edition of Deutsches rzteblatt Internat..., Uwe Zeimer et al. present the German results of ...ne or more cardiovascular diseases and 10.8% only ...
...dge Healthtech Institute’s (CHI) flagship ev...ry 24-27, 2009) will feature four of molecular med... , Needham, MA (PRWEB) No...l feature four of molecular medicine’s thoug...
...ersonal stories of living with HIV/AIDS , , W...eath for African American women ages 25-34 today. ... year if all HIV infected persons knew of their in...d this week at the 2008 National Summit on HIV Dia...
Other Medicine News:Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 2Health News:A Recommended Sales and Use Tax Proposed by Governor Schwarzenegger Will Tax Veterinary Services, Says Social Compassion in Legislation 3Health News:Four of Molecular Medicine's Thought Leaders will Keynote at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference 2Health News:Four of Molecular Medicine's Thought Leaders will Keynote at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference 3Health News:Four of Molecular Medicine's Thought Leaders will Keynote at Cambridge Healthtech Institute's Molecular Medicine Tri-Conference 4Health News:Southern AIDS Living Quilt Raises Awareness at National HIV Summit 2
(Date:12/3/2009)... A genetic variation that...entially life-threatening blood disorder if expose... is one of several medical discoveries scientists ...SE: DGX ) will present during the 51st American ...osition, December 5-8, 2009, in New Orleans, LA. ...
(Date:12/3/2009)...Dec. 3 Ted Karkus, Chair...QGLY ) www.quigleyco.com announced today that th...rtunities to develop prescription pharmaceutical a...s best interests to focus primarily on the OTC/Per...not limited to its Cold-EEZE® and Kids-EEZE&#...
(Date:12/3/2009)...a., Dec. 3 Radiology imaging leade... integration capabilities at the November 2009 Rad...Connect.PACS(TM) product, enabling the first radi... latest release in the company,s newly branded Ce... http://www.newscom.com/cgi-bin/prnh/20091203/NE2...
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Scientists shed new light on behavior of shark tweens and teenagers 9686 1Scientists shed new light on behavior of shark tweens and teenagers 9686 2Scientists shed new light on behavior of shark tweens and teenagers 9686 3Nick Jonas Speaks at National Press Club in Effort to Educate Support and Inspire Kids With Diabetes 55174 1Nick Jonas Speaks at National Press Club in Effort to Educate Support and Inspire Kids With Diabetes 55174 2Nick Jonas Speaks at National Press Club in Effort to Educate Support and Inspire Kids With Diabetes 55174 3Nick Jonas Speaks at National Press Club in Effort to Educate Support and Inspire Kids With Diabetes 55174 4Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as Of Counsel 55171 1Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as Of Counsel 55171 2Decorated Trial Attorney Conard Metcalf Joins Simmons Firm as Of Counsel 55171 3
...Widespread Use, Formulary Coverage of Targeted Can...ew Report from Decision Resources, WALTHAM, Mass....leading research and advisory firms for pharmaceut...y targeted cancer agents in Phase,III clinical tri...say that,Genentech/Roche/Chugai,s Avastin in early...
...Oct. 14 Paratek Pharmaceuticals, Inc. today,annou...merly PTK 0796, a,first-in-class aminomethylcyclin...esentation at the 48th Interscience Conference on ...AC will be held in Washington, D.C.,from October 2...ster session at ICAAC:, Sunday, October 26, 12:...
Other Medicine Technology:Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer 2Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer 3Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2
Medium Clip Appliers
Li Brand™ Surgical Hemostat
The 2201
No Scalpel Vasectomy Hemostat
Medicine Products: